Ludwig Cancer Research engages leading scientists and clinicians in an integrated effort to understand and confront the challenge of cancer. The Oxford Branch is based at the University of Oxford and benefits from excellent links with the global Ludwig and local Oxford research communities.
The Royal Society has awarded Professor Sir Peter Ratcliffe the Buchanan Medal for his ground-breaking research on oxygen sensing and signalling pathways mediating cellular responses to low oxygen levels or 'hypoxia'. Peter Ratcliffe is a member of the Ludwig Institute for Cancer Research in Oxford, Director of the Target Discovery Group at the University of Oxford and Clinical Research Director at the Francis Crick Institute.
The Association of Medical Research Charities, of which the Ludwig Institute for Cancer Research is a member, has published an overview of how medical research charities are working in cancer research in the UK.
All roads lead to ubiquitin. Cell Death Differ, 24 (7), pp. 1135-1136. Article
Cell scientist to watch - Mads Gyrd-Hansen. J Cell Sci, 130 (12), pp. 1981-1983. Article
New horizons in hypoxia signaling pathways. Exp Cell Res, 356 (2), pp. 116-121. Article
Update on hypoxia-inducible factors and hydroxylases in oxygen regulatory pathways: from physiology to therapeutics. Hypoxia (Auckl), 5, pp. 11-20. Article
Analysis of live cell images: Methods, tools and opportunities. Methods, 115, pp. 65-79. Article
Our researchers are investigating all stages of cancer, from the risk of disease through to new treatment opportunities. Many of the research groups are interested the causes and consequences of differences among cells within a tumour and variability among different tumours. Find out more about the Ludwig research groups.
Ludwig Seminars take place in the NDMRB (TDI) Basement Seminar Room. All University members welcome.
Georg Hollander: Title TBC, 12/Oct/2017 11:00
Browse the Ludwig Seminar Series